United Capital Financial Advisors’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-3,814
Closed -$350K 1226
2021
Q4
$350K Sell
3,814
-2,592
-40% -$310K ﹤0.01% 971
2021
Q3
$812K Sell
6,406
-1,403
-18% -$204K ﹤0.01% 731
2021
Q2
$1.3M Sell
7,809
-9,706
-55% -$1.57M 0.01% 632
2021
Q1
$3.18M Sell
17,515
-1,803
-9% -$418K 0.02% 423
2020
Q4
$3.86M Buy
19,318
+9,870
+104% +$2.01M 0.02% 396
2020
Q3
$2.07M Buy
9,448
+713
+8% +$151K 0.01% 488
2020
Q2
$1.67M Buy
8,735
+593
+7% +$104K 0.01% 553
2020
Q1
$1.26M Sell
8,142
-939
-10% -$109K 0.01% 582
2019
Q4
$760K Buy
9,081
+666
+8% +$50.7K ﹤0.01% 872
2019
Q3
$570K Buy
+8,415
New +$554K ﹤0.01% 915
2019
Q2
Sell
-13,635
Closed -$758K 1494
2019
Q1
$758K Buy
+13,635
New +$832K 0.01% 854

Other funds holding TDOC

United Capital Financial Advisors's TDOC Position: Q1 2022 in Review

United Capital Financial Advisors sold out of Teladoc Health (TDOC) in Q1 2022, closing a stake of 3,814 shares — an estimated $350K sold.

United Capital Financial Advisors first reported a position in TDOC in Q1 2019 and held it in 11 quarters. The position peaked at $3.86M in Q4 2020. 679 funds tracked by Wall St. Rank hold TDOC as of Q1 2022.

  • United Capital Financial Advisors reported no remaining Teladoc Health position as of Q1 2022 after selling out during the quarter.
  • United Capital Financial Advisors sold 3,814 Teladoc Health shares in Q1 2022, an estimated $350K.
  • United Capital Financial Advisors first reported a position in Teladoc Health in Q1 2019 and held it in 11 quarters.
  • United Capital Financial Advisors's Teladoc Health position peaked at $3.86M in Q4 2020.
  • 679 funds tracked by Wall St. Rank held Teladoc Health as of Q1 2022.

Based on United Capital Financial Advisors's 13F filing for Q1 2022, filed 16 May 2022.